Delcath Systems, Inc.
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery s…
Medical - Specialties
US, New York [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Delcath Systems, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDDelcath Systems, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Delcath Systems, Inc..
If you want to see a demo, head over to the financial segments of AAPL